1. Home
  2. MRAM vs ACIU Comparison

MRAM vs ACIU Comparison

Compare MRAM & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$8.00

Market Cap

183.3M

Sector

Technology

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.96

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
ACIU
Founded
2008
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
183.3M
213.3M
IPO Year
2016
2016

Fundamental Metrics

Financial Performance
Metric
MRAM
ACIU
Price
$8.00
$2.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.50
$10.00
AVG Volume (30 Days)
238.2K
241.6K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,642,000.00
$5,482,957.00
Revenue This Year
$10.80
N/A
Revenue Next Year
$13.42
$1,022.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$1.43
52 Week High
$12.27
$4.00

Technical Indicators

Market Signals
Indicator
MRAM
ACIU
Relative Strength Index (RSI) 40.10 44.78
Support Level $7.48 $2.70
Resistance Level $8.42 $3.13
Average True Range (ATR) 0.39 0.21
MACD -0.07 -0.05
Stochastic Oscillator 26.71 32.50

Price Performance

Historical Comparison
MRAM
ACIU

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: